Coral Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
680.10
16.35 (2.46%)
BSENSE

Nov 20

BSE+NSE Vol: 9.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Coral Labs.
Sanjiv.Parant.
BDH Industries
Gennex Lab.
Everest Organics
Brooks Lab.
Zenotech Lab.
Nectar Lifesci.
Kerala Ayurveda
Accretion Pha.
Sat Kartar Life
Why is Coral Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Net Sales of 91.12%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 2 consecutive quarters
  • NET SALES(Q) Highest at Rs 36.37 cr
  • PBDIT(Q) Highest at Rs 9.32 cr.
  • PBT LESS OI(Q) Highest at Rs 8.65 cr.
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 20-Nov-26
  • The stocks MACD and Bollinger Band technical factors are also Bullish
4
With ROE of 9.7, it has a Attractive valuation with a 1.1 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 35.33%, its profits have risen by 23.9% ; the PEG ratio of the company is 0.5
5
Majority shareholders : Promoters
6
Market Beating performance in long term as well as near term
  • Along with generating 35.33% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Coral Labs. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Coral Labs. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Coral Labs.
35.33%
0.77
45.89%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.00%
EBIT Growth (5y)
10.30%
EBIT to Interest (avg)
13.34
Debt to EBITDA (avg)
0.29
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.49
Tax Ratio
26.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.45%
ROE (avg)
7.87%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
11
Industry P/E
40
Price to Book Value
1.07
EV to EBIT
7.41
EV to EBITDA
6.59
EV to Capital Employed
1.12
EV to Sales
1.32
PEG Ratio
0.46
Dividend Yield
0.29%
ROCE (Latest)
15.17%
ROE (Latest)
9.67%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company
NET SALES(Q)

Highest at Rs 36.37 cr

PBDIT(Q)

Highest at Rs 9.32 cr.

PBT LESS OI(Q)

Highest at Rs 8.65 cr.

PAT(Q)

Highest at Rs 8.49 cr.

EPS(Q)

Highest at Rs 23.78

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 2.71 times

Loading Valuation Snapshot...
Here's what is working for Coral Labs.
Net Sales - Quarterly
At Rs 36.37 cr has Grown at 91.12%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 8.65 cr has Grown at 97.04%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 36.37 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 8.49 cr has Grown at 52.5%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 9.32 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 8.65 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 8.49 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 23.78
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Coral Labs.
Debtors Turnover Ratio- Half Yearly
Lowest at 2.71 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio